Niki BioSolutions, Inc. (NIKI) vs PRF Technologies Ltd. (PRFX)

A side-by-side comparison of Niki BioSolutions, Inc. and PRF Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NIKI vs PRFX

growth of $100 · dividends reinvested · last 6y
NIKI -99.8% (-63.6%/yr)PRFX -100.0% (-72.4%/yr)NIKI compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $100202120222023202420252026$0$0
NIKI PRFX

NIKI vs PRFX: by the numbers

  • •NIKI is the larger company ($381940 vs $71110 market cap).
  • •Both run net losses; NIKI's is the smaller (0.00% vs -22521.52% net margin).

Metrics side by side

Valuation

MetricNIKIPRFX
P/S ratioN/A1.80
P/B ratio0.020.00

Profitability

MetricNIKIPRFX
Gross margin0.00%-4864.71%
Operating margin0.00%-29335.29%
Net margin0.00%-22521.52%
ROE-5.89%-56.04%
ROIC-10.38%-53.95%

Growth (annualized)

MetricNIKIPRFX
Total return CAGR (5Y)-71.40%-74.50%

Frequently asked

How have NIKI and PRFX total returns compared?
Over the past 5 years, NIKI delivered -71.40% and PRFX delivered -74.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.